Our Vision

Print

The identification of new biomarkers is an increasingly essential element of predictive, preventive, and personalized medicine. To meet this need, The Biomarkers Consortium's projects serve to develop and qualify promising biomarkers in order to help accelerate the delivery of successful new technologies, medicines, and therapies for prevention, early detection, diagnosis, and treatment of disease.


Goals

To achieve this end, The Biomarkers Consortium will:

  • Facilitate the development and validation of biomarkers using new and existing technologies.
  • Help qualify these biomarkers for specific applications in diagnosing disease, predicting therapeutic response, or improving clinical practice. 
  • Generate information useful to inform regulatory decision-making
  • Make consortium project results broadly available to the entire scientific community  
To support these goals, the Biomarkers Consortium has established four disease/therapeutic area-specific Steering Committees comprised of experts in each area to initiate or review specific project concepts and develop them into full project proposals.  We encourage the submission of suitable biomarker project concepts to the appropriate Steering Committee.  Once fully developed by a Steering Committee, projects are given final review and approval by the Consortium’s Executive Committee, which represents the founding partners of the Consortium and provides strategic direction for its activities.  (Concepts that fall outside the four Steering Committee disease areas may still be submitted generally to the Consortium and be considered by the Executive Committee.)  Once a project is approved by the Executive Committee, the Foundation for NIH undertakes formal fundraising efforts on its behalf.

The information and research results from consortium projects are made publicly available and released as rapidly as possible to promote the use of biomarkers to improve public health. For more information, see our Policies and Procedures.

The Foundation for NIH actively seeks additional partners to support the operations and central activities of The Biomarkers Consortium and its projects. To learn more about our partner model, and find out how to join the consortium, view our Partners page.